{"id":686,"date":"2026-07-01T13:00:00","date_gmt":"2026-07-01T04:00:00","guid":{"rendered":"https:\/\/cellfiber.jp\/en\/?p=686"},"modified":"2026-06-30T17:19:39","modified_gmt":"2026-06-30T08:19:39","slug":"20260701_news_newgeneralmanager","status":"publish","type":"post","link":"https:\/\/cellfiber.jp\/en\/20260701_news_newgeneralmanager\/","title":{"rendered":"\u200b\u200bWelcoming Dr. Shannon Eaker as General Manager, United States"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">\u200b\u200b\u200bCellFiber\u00a0is pleased to announce that Dr. Shannon Eaker has joined the company as General Manager, US. In this role, Dr. Eaker will lead\u00a0CellFiber\u2019s\u00a0expansion into the United States, driving the company\u2019s commitment to our Biopharmaceutical, Therapeutic and CDMO partners as demand grows for scalable cell and gene therapy and generative medicine manufacturing solutions in the US.\u00a0\u200b\u200b\u200b\u00a0\u00a0\u00a0\u00a0\u00a0\u200b\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u200b\u200b\u200bWith over 15 years of experience in the Cell and Gene Therapy\u200b\u200b\u00a0\u200b\u200band Regenerative Medicine industries, Dr. Eaker has held senior roles including Chief Technology Officer at\u00a0Xcell\u00a0Biosciences and Cell Therapy Enterprise Solutions Leader at\u00a0Cytiva\u00a0(formerly General Electric). His\u00a0expertise\u00a0includes advancing end-to-end manufacturing technologies that enable therapeutic scale-up under tight timelines and budgets, across multiple modalities and applications including T-cell therapies and stem cell-derived workflows. He is also an active member of the International Society for Cell &amp; Gene Therapy (ISCT) and Regenerative Medicine Manufacturing Society (RMMS).\u00a0\u200b\u200b\u200b\u00a0\u00a0\u00a0\u00a0\u00a0\u200b\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">General Manager, US. In this role, Dr. Eaker will lead\u202fCellFiber\u2019s\u202fexpansion into the United States, driving the company\u2019s commitment to our Biopharmaceutical, Therapeutic and CDMO partners as demand grows for scalable cell and gene therapy and generative medicine manufacturing solutions in the US.\u202fGeneral Manager, US. In this role, Dr. Eaker will lead\u202fCellFiber\u2019s\u202fexpansion into the United States, driving the company\u2019s commitment to&nbsp;our Biopharmaceutical, Therapeutic and CDMO partners as demand grows for scalable cell and gene therapy and generative medicine manufacturing solutions in the US.\u202f&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u200b\u200b\u200bAs&nbsp;CellFiber&nbsp;continues to scale its&nbsp;Zeito&nbsp;platform across the US market, Dr. Eaker\u2019s appointment reflects the company\u2019s commitment to building deep, technical partnerships with the developers and manufacturers shaping the future of Cell and Gene Therapy and Regenerative Medicines.&nbsp;\u200b\u200b\u200b&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\u200b&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u200b\u200b\u200bCellFiber&nbsp;welcomes Dr. Eaker to the team and looks forward to his leadership as the company grows its presence in the United States.\u200b\u200b&nbsp;\u200b\u200b&nbsp;\u200b\u200b\u200b&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\u200b&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u200b\u200b\u200bCellFiber\u00a0is pleased to announce that Dr. Shannon Eaker has joined the company as General Manager, US. In this role, Dr. Eaker will lead\u00a0CellFiber\u2019s\u00a0expansion into the United States, driving the company\u2019s commitment to our Biopharmaceutical, Therapeutic and CDMO partners as demand grows for scalable cell and gene therapy and generative medicine manufacturing solutions in the US.\u00a0\u200b\u200b\u200b\u00a0\u00a0\u00a0\u00a0\u00a0\u200b\u00a0 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-686","post","type-post","status-publish","format-standard","hentry","category-others"],"_links":{"self":[{"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/posts\/686","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/comments?post=686"}],"version-history":[{"count":2,"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/posts\/686\/revisions"}],"predecessor-version":[{"id":688,"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/posts\/686\/revisions\/688"}],"wp:attachment":[{"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/media?parent=686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/categories?post=686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cellfiber.jp\/en\/wp-json\/wp\/v2\/tags?post=686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}